Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer

Sten Holmäng, Sonny L. Johansson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective. To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter. Material and methods. A clinical and histopathological review was performed on 943 patients with a primary malignant tumour in the renal pelvis and ureter. We selected 394 patients who had macrohaematuria as an initial symptom, had no previous history of bladder cancer, had undergone surgery and had adequate follow-up. We performed uni- and multivariate analyses of prognostic factors for disease-specific survival. Results. The median number of days between the first occurrence of macrohaematuria and surgery was 83.5 days (range 4-1770 days). Patients with advanced tumours had the shortest median delay. Advanced tumour stage, a solid growth pattern and vascular invasion were of prognostic importance for disease-specific survival in the multivariate analysis, but diagnostic and treatment delay were not. Conclusions. Although the delay was unacceptably long it still had no impact on survival, probably because macroscopic haematuria is a late symptom, in particular in high-grade tumours. New screening methods for the early detection of cancer and new treatment modalities are needed to improve the poor prognosis in stage pT3-pT4 tumours.

Original languageEnglish (US)
Pages (from-to)479-484
Number of pages6
JournalScandinavian Journal of Urology and Nephrology
Volume40
Issue number6
DOIs
StatePublished - Dec 1 2006

Fingerprint

Ureteral Neoplasms
Pelvic Neoplasms
Kidney Neoplasms
Survival
Neoplasms
Kidney Pelvis
Ureter
Therapeutics
Multivariate Analysis
Hematuria
Early Detection of Cancer
Urinary Bladder Neoplasms
Blood Vessels

Keywords

  • Delay
  • Malignant tumours
  • Renal pelvis
  • Survival
  • Ureter

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer. / Holmäng, Sten; Johansson, Sonny L.

In: Scandinavian Journal of Urology and Nephrology, Vol. 40, No. 6, 01.12.2006, p. 479-484.

Research output: Contribution to journalArticle

@article{b8b568fd804b49169160f7bab2aee404,
title = "Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer",
abstract = "Objective. To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter. Material and methods. A clinical and histopathological review was performed on 943 patients with a primary malignant tumour in the renal pelvis and ureter. We selected 394 patients who had macrohaematuria as an initial symptom, had no previous history of bladder cancer, had undergone surgery and had adequate follow-up. We performed uni- and multivariate analyses of prognostic factors for disease-specific survival. Results. The median number of days between the first occurrence of macrohaematuria and surgery was 83.5 days (range 4-1770 days). Patients with advanced tumours had the shortest median delay. Advanced tumour stage, a solid growth pattern and vascular invasion were of prognostic importance for disease-specific survival in the multivariate analysis, but diagnostic and treatment delay were not. Conclusions. Although the delay was unacceptably long it still had no impact on survival, probably because macroscopic haematuria is a late symptom, in particular in high-grade tumours. New screening methods for the early detection of cancer and new treatment modalities are needed to improve the poor prognosis in stage pT3-pT4 tumours.",
keywords = "Delay, Malignant tumours, Renal pelvis, Survival, Ureter",
author = "Sten Holm{\"a}ng and Johansson, {Sonny L.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1080/00365590600864093",
language = "English (US)",
volume = "40",
pages = "479--484",
journal = "Scandinavian Journal of Urology",
issn = "2168-1805",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Impact of diagnostic and treatment delay on survival in patients with renal pelvic and ureteral cancer

AU - Holmäng, Sten

AU - Johansson, Sonny L.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Objective. To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter. Material and methods. A clinical and histopathological review was performed on 943 patients with a primary malignant tumour in the renal pelvis and ureter. We selected 394 patients who had macrohaematuria as an initial symptom, had no previous history of bladder cancer, had undergone surgery and had adequate follow-up. We performed uni- and multivariate analyses of prognostic factors for disease-specific survival. Results. The median number of days between the first occurrence of macrohaematuria and surgery was 83.5 days (range 4-1770 days). Patients with advanced tumours had the shortest median delay. Advanced tumour stage, a solid growth pattern and vascular invasion were of prognostic importance for disease-specific survival in the multivariate analysis, but diagnostic and treatment delay were not. Conclusions. Although the delay was unacceptably long it still had no impact on survival, probably because macroscopic haematuria is a late symptom, in particular in high-grade tumours. New screening methods for the early detection of cancer and new treatment modalities are needed to improve the poor prognosis in stage pT3-pT4 tumours.

AB - Objective. To investigate the relationships between diagnostic and treatment delay and tumour stage and survival among patients with malignant tumours in the renal pelvis and ureter. Material and methods. A clinical and histopathological review was performed on 943 patients with a primary malignant tumour in the renal pelvis and ureter. We selected 394 patients who had macrohaematuria as an initial symptom, had no previous history of bladder cancer, had undergone surgery and had adequate follow-up. We performed uni- and multivariate analyses of prognostic factors for disease-specific survival. Results. The median number of days between the first occurrence of macrohaematuria and surgery was 83.5 days (range 4-1770 days). Patients with advanced tumours had the shortest median delay. Advanced tumour stage, a solid growth pattern and vascular invasion were of prognostic importance for disease-specific survival in the multivariate analysis, but diagnostic and treatment delay were not. Conclusions. Although the delay was unacceptably long it still had no impact on survival, probably because macroscopic haematuria is a late symptom, in particular in high-grade tumours. New screening methods for the early detection of cancer and new treatment modalities are needed to improve the poor prognosis in stage pT3-pT4 tumours.

KW - Delay

KW - Malignant tumours

KW - Renal pelvis

KW - Survival

KW - Ureter

UR - http://www.scopus.com/inward/record.url?scp=33751580738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751580738&partnerID=8YFLogxK

U2 - 10.1080/00365590600864093

DO - 10.1080/00365590600864093

M3 - Article

C2 - 17130100

AN - SCOPUS:33751580738

VL - 40

SP - 479

EP - 484

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

SN - 2168-1805

IS - 6

ER -